Literature DB >> 20551718

Species neutral correlates of immunogenicity for vaccines and protein therapeutics: fact or science fiction.

Anne S De Groot1, Matthew Baker, Tobias Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20551718      PMCID： PMC2943984     

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN： 1554-8600


× No keyword cloud information.
  18 in total

Review 1.  Major histocompatibility complex class II polymorphisms in primates.

Authors:  R E Bontrop; N Otting; N G de Groot; G G Doxiadis
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

2.  A human lymph node in vitro--challenges and progress.

Authors:  Christoph Giese; Christian D Demmler; Richard Ammer; Stefan Hartmann; Annika Lubitz; Lilja Miller; Riccarda Müller; Uwe Marx
Journal:  Artif Organs       Date:  2006-10       Impact factor: 3.094

Review 3.  Identification and removal of immunogenicity in therapeutic proteins.

Authors:  Matthew P Baker; Timothy D Jones
Journal:  Curr Opin Drug Discov Devel       Date:  2007-03

Review 4.  CD40 ligation in B cell activation, isotype switching and memory development.

Authors:  D Gray; K Siepmann; G Wohlleben
Journal:  Semin Immunol       Date:  1994-10       Impact factor: 11.130

Review 5.  Neutralizing antiviral B cell responses.

Authors:  M F Bachmann; R M Zinkernagel
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule.

Authors:  H P Brok; A Uccelli; N Kerlero De Rosbo; R E Bontrop; L Roccatagliata; N G de Groot; E Capello; J D Laman; K Nicolay; G L Mancardi; A Ben-Nun; B A Hart
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  Clinical link between MHC class II haplotype and interferon-beta (IFN-beta) immunogenicity.

Authors:  Maria D F S Barbosa; Jost Vielmetter; Seung Chu; David D Smith; Jonathan Jacinto
Journal:  Clin Immunol       Date:  2005-11-02       Impact factor: 3.969

8.  Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.

Authors:  Julie A McMurry; Sarah Kimball; Jin Hee Lee; Daniel Rivera; William Martin; David B Weiner; Michele Kutzler; David R Sherman; Hardy Kornfeld; Anne S De Groot
Journal:  Curr Mol Med       Date:  2007-06       Impact factor: 2.222

9.  An immunologic model for rapid vaccine assessment -- a clinical trial in a test tube.

Authors:  Russell G Higbee; Anthony M Byers; Vipra Dhir; Donald Drake; Heather G Fahlenkamp; Jyoti Gangur; Anatoly Kachurin; Olga Kachurina; Del Leistritz; Yifan Ma; Riyaz Mehta; Eric Mishkin; Janice Moser; Luis Mosquera; Mike Nguyen; Robert Parkhill; Santosh Pawar; Louis Poisson; Guzman Sanchez-Schmitz; Brian Schanen; Inderpal Singh; Haifeng Song; Tenekua Tapia; William Warren; Vaughan Wittman
Journal:  Altern Lab Anim       Date:  2009-09       Impact factor: 1.303

10.  Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction.

Authors:  D Gray; P Dullforce; S Jainandunsing
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.